"ClinRx Research is dedicated to advancing medicine and enhancing quality of life by providing patients the opportunity to contribute to new therapeutic advances through excellence in the management of clinical research services. We provide an opportunity for our patients to safely participate in the evaluation of new medical products which are not yet available for general use with no cost to them."

During the past decade, ClinRx Research, LLC conducted 15 clinical trials. In the 10-year time frame, 15 clinical trials started and 13 clinical trials were completed, i.e. on average, 86.7% percent of trials that started reached the finish line to date. In the past 5 years, 9 clinical trials started and 10 clinical trials were completed. i.e. 111.1% of trials that started reached the finish line.

Out of the total clinical trials conducted in "ClinRx Research, LLC" #1 sponsor was "Allergan" with 4 trials, followed by "Bayer" with 3 trials sponsored, "Pfizer" with 3 trials sponsored, "Pfizer's Upjohn has merged with Mylan to form Viatris Inc." with 3 trials sponsored and "Astellas Pharma Global Development, Inc." with 3 trials sponsored. Other sponsors include 2 different institutions and companies that sponsored additional 12 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "ClinRx Research, LLC" #1 collaborator was "Eli Lilly and Company" with 1 trials as a collaborator and "Incyte Corporation" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "ClinRx Research, LLC" are "Gastroparesis" (4 trials), "Diabetes Mellitus" (3 trials), "Hot Flashes" (3 trials), "Osteoarthritis" (2 trials) and "Osteoarthritis, Hip" (2 trials). Many other conditions were trialed in "ClinRx Research, LLC" in a lesser frequency.

Most popular intervention types in "ClinRx Research, LLC" are "Drug" (22 trials), "Other" (3 trials) and "Biological" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (10 trials), "placebo" (5 trials), "Relamorelin" (3 trials), "Apixaban" (1 trials) and "Apixaban matching placebo" (1 trials). Other intervention names were less common.

The vast majority of trials in "ClinRx Research, LLC" are 19 trials for "All" genders and 3 trials for "Female" genders.

Currently, there are NaN active trials in "ClinRx Research, LLC". undefined are not yet recruiting, 2 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 11 completed trials in ClinRx Research, LLC, undefined suspended trials, and 6 terminated clinical trials to date.

Out of the total trials that were conducted in ClinRx Research, LLC, 0 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 17 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".